Key result
High CADILLAC score and high CAR linked to ~8-fold greater risk of 1-year major cardiovascular events.
Why the study?
Acute myocardial infarction remains a leading cause of morbidity and mortality, making accurate early risk stratification essential for predicting adverse events.
Does combining the C-reactive protein/albumin ratio (CAR) with the CADILLAC risk score improve the prediction of 1-year MACE in patients with acute myocardial infarction undergoing primary PCI?
Cohort (n=554)
No
Does combining the C-reactive protein/albumin ratio (CAR) with the CADILLAC risk score improve the prediction of 1-year MACE in patients with acute myocardial infarction undergoing primary PCI?
Combining the C-reactive protein/albumin ratio with the CADILLAC risk score significantly improves the prediction of 1-year major adverse cardiac events in patients with acute myocardial infarction undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
High CAR with high CADILLAC score was associated with increased 1-year MACE after AMI; hypothesis-generating for improved stratification and requires prospective validation.
Background: Acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality, so accurate early risk stratification is essential for predicting adverse events. We investigated whether combining the Creactive protein/albumin ratio (CAR) with the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) risk score was associated with an increased risk of 1-year major adverse cardiac events (MACE), and assessed its efficacy in the risk stratification of patients with AMI undergoing primary percutaneous coronary intervention (PCI).
No takes yet. Share an insight, caveat, or question.
Oguri et al. (2026) conducted a cohort in Acute myocardial infarction (AMI) (n=554). High CADILLAC risk score and high C-reactive protein/albumin ratio (CAR) vs. Low CADILLAC risk score and low CAR was evaluated on 1-year major adverse cardiac events (MACE) (HR 8.13, 95% CI 1.88-35.2, p=0.005). Compared to patients with a low CADILLAC risk score and a low C-reactive protein/albumin ratio (CAR), those with a high CADILLAC risk score and a high CAR had a increased risk of 1-year major adverse cardiac events.
Synapse has enriched 10 related papers. Consider them for comparative context: